ALS2CR12 Antibody [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05958G
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ALS2CR12 Antibody [DyLight 488]
Immunogen
Produced in rabbits immunized with E. coli-derived Human ALS2CR12 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ALS2CR12 Antibody [DyLight 488]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ALS2CR12
Alternate Names
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12
Gene Symbol
FLACC1
Additional ALS2CR12 Products
Product Documents for ALS2CR12 Antibody [DyLight 488]
Product Specific Notices for ALS2CR12 Antibody [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...